RSNA 2014 

Abstract Archives of the RSNA, 2014


VSPD31-13

Long-term Outcome of Percutaneous Transhepatic Balloon Angioplasty for Portal Vein Stenosis after Pediatric Living Donor Liver Transplantation

Scientific Papers

Presented on December 2, 2014
Presented as part of VSPD31: Pediatric Series: CV/IR  

Participants

Minoru Yabuta MD, Presenter: Nothing to Disclose
Toshiya Shibata MD, Abstract Co-Author: Nothing to Disclose
Rinpei Imamine, Abstract Co-Author: Nothing to Disclose
Ken Shinozuka MD, Abstract Co-Author: Nothing to Disclose
Hiroyoshi Isoda MD, Abstract Co-Author: Nothing to Disclose
Kaori Togashi MD, PhD, Abstract Co-Author: Research Grant, Bayer AG Research Grant, DAIICHI SANKYO Group Research Grant, Eisai Co, Ltd Research Grant, FUJIFILM Holdings Corporation Research Grant, Nihon Medi-Physics Co, Ltd Research Grant, Shimadzu Corporation Research Grant, Toshiba Corporation Research Grant, Covidien AG

PURPOSE

To retrospectively evaluate the long-term outcomes of percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation.

METHOD AND MATERIALS

Between October 1997 and December 2013, 43 patients (19 boys, 24 girls; mean age, 4.1 years) who had undergone living donor liver transplantation were confirmed to have portal vein stenosis at direct portography with or without manometry, and underwent percutaneous interventions, including balloon angioplasty with or without stent placement. Technical success, patency rates and major complications were evaluated. Follow-up periods after the initial balloon angioplasty ranged from 5 months to 169 months (mean, 119 months).

RESULTS

Technical success was achieved in 65 of 66 sessions (98.5%) and in 42 of 43 patients (97.7%). At 1, 3, 5, and 10 years after the first percutaneous transhepatic balloon angioplasty, the rates of primary patency were 83%, 78%, 76% and 70%, respectively, and the rates of primary-assisted patency were 100%, 100%, 100% and 96%, respectively. In major complication, severe asthma attack and portal vein thrombosis subsequent to balloon angioplasty were noted.

CONCLUSION

Percutaneous transhepatic balloon angioplasty for portal vein stenosis after pediatric living donor liver transplantation was safe and effective.

CLINICAL RELEVANCE/APPLICATION

Percutaneous transhepatic balloon angioplasty might be a safe and effective treatment for portal vein stenosis after pediatric living donor liver transplantation.

Cite This Abstract

Yabuta, M, Shibata, T, Imamine, R, Shinozuka, K, Isoda, H, Togashi, K, Long-term Outcome of Percutaneous Transhepatic Balloon Angioplasty for Portal Vein Stenosis after Pediatric Living Donor Liver Transplantation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14000327.html